Literature DB >> 10431001

II. Incidence and prevalence of ESRD.

.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10431001     DOI： 10.1053/AJKD034s00040

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  4 in total

1.  Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease.

Authors:  Murthy N Darisipudi; Onkar P Kulkarni; Sufyan G Sayyed; Mi Ryu; Adriana Migliorini; Costanza Sagrinati; Eliana Parente; Axel Vater; Dirk Eulberg; Sven Klussmann; Paola Romagnani; Hans-Joachim Anders
Journal:  Am J Pathol       Date:  2011-04-30       Impact factor: 4.307

Review 2.  Recent advances in the pathophysiology of nephrolithiasis.

Authors:  Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-12-10       Impact factor: 10.612

Review 3.  Pharmacology of stone disease.

Authors:  Khashayar Sakhaee
Journal:  Adv Chronic Kidney Dis       Date:  2009-01       Impact factor: 3.620

4.  Experience with an extended-release opioid formulation designed to reduce abuse liability in a community-based pain management clinic.

Authors:  Daniel Rubino
Journal:  Int J Gen Med       Date:  2011-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.